Literature DB >> 16455365

Evaluation of type 3 portable monitoring in unattended home setting for suspected sleep apnea: factors that may affect its accuracy.

Min Yin1, Soichiro Miyazaki, Kazuo Ishikawa.   

Abstract

OBJECTIVE: This study evaluates the reliability of type 3 portable monitoring (PM) in a home setting. STUDY DESIGN AND
SETTING: Prospective study in sleep laboratory. Type 3 device (Stardust II) was evaluated in comparison with standard polysomnography (PSG) among patients with obstructive sleep apnea. Quality of recorded data and agreement between PM and PSG results were evaluated.
RESULTS: Low quality of recorded data was observed only in 5 cases. Pattern of disordered breathing was recognized correctly by PM. Apnea/hypopnea index (AHI) correlated well with a mean bias of 3.7 +/- 13.1/h. High sensitivity of PM was observed generally, whereas specificity was lower in mild patients. AHI, record time, and sleep position were found to be the main factors that would affect the accuracy of PM.
CONCLUSION: Type 3 PM is feasible in unattended home-setting for routine examination. Influence of the factors above should be comprehensively considered especially for mild patients.

Entities:  

Mesh:

Year:  2006        PMID: 16455365     DOI: 10.1016/j.otohns.2005.10.019

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  23 in total

1.  Perioperative practical experiences in using a level 2 portable polysomnography.

Authors:  Frances Chung; Pu Liao; Yuming Sun; Babak Amirshahi; Hoda Fazel; Colin M Shapiro; Hisham Elsaid
Journal:  Sleep Breath       Date:  2010-03-16       Impact factor: 2.816

Review 2.  Obstructive sleep apnea devices for out-of-center (OOC) testing: technology evaluation.

Authors:  Nancy A Collop; Sharon L Tracy; Vishesh Kapur; Reena Mehra; David Kuhlmann; Sam A Fleishman; Joseph M Ojile
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

3.  Survey regarding limited diagnostic systems for sleep apnea.

Authors:  Philip R Westbrook
Journal:  J Clin Sleep Med       Date:  2007-04-15       Impact factor: 4.062

4.  Impact of clinical assessment on use of data from unattended limited monitoring as opposed to full-in lab PSG in sleep disordered breathing.

Authors:  Maria Jose Masdeu; Indu Ayappa; Dennis Hwang; Anne M Mooney; David M Rapoport
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

Review 5.  Methodological strategies in using home sleep apnea testing in research and practice.

Authors:  Jennifer N Miller; Paula Schulz; Bunny Pozehl; Douglas Fiedler; Alissa Fial; Ann M Berger
Journal:  Sleep Breath       Date:  2017-11-14       Impact factor: 2.816

6.  Patient-predicted sleep position vs. HST data: a tendency to underestimate supine sleep.

Authors:  Adam J Sorscher; Anthony P Anzivino; Todd Mackenzie
Journal:  Sleep Breath       Date:  2017-11-17       Impact factor: 2.816

7.  Diagnostic accuracy of home-based monitoring system in morbidly obese patients with high risk for sleep apnea.

Authors:  Márcia G Oliveira; Erika C Treptow; Cesar Fukuda; Luiz E Nery; Rosana M Valadares; Sérgio Tufik; Lia Bittencourt; Sonia M Togeiro
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

8.  A pilot validation study for the NOX T3(TM) portable monitor for the detection of OSA.

Authors:  Alyssa Cairns; Emerson Wickwire; Edward Schaefer; David Nyanjom
Journal:  Sleep Breath       Date:  2014-01-19       Impact factor: 2.816

Review 9.  Diagnostic accuracy of level 3 portable sleep tests versus level 1 polysomnography for sleep-disordered breathing: a systematic review and meta-analysis.

Authors:  Mohamed El Shayeb; Leigh-Ann Topfer; Tania Stafinski; Lawrence Pawluk; Devidas Menon
Journal:  CMAJ       Date:  2013-11-11       Impact factor: 8.262

10.  Validation of a self-applied unattended monitor for sleep disordered breathing.

Authors:  Indu Ayappa; Robert G Norman; Vijay Seelall; David M Rapoport
Journal:  J Clin Sleep Med       Date:  2008-02-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.